Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6557963 | 0.69 | TSHR (0.48) | TSHR | |
| SCHEMBL7627471 | 0.67 | TSHR (0.46) | TSHR | |
| SCHEMBL3847162 | 0.62 | — | — | |
| SCHEMBL11791026 | 0.62 | CHRNB2 (0.47) | TSHR | |
| SCHEMBL150988 | 0.62 | TSHR (0.32) | TSHR | |
| SCHEMBL5376527 | 0.62 | TSHR (0.41) | TSHR | |
| SCHEMBL1072862 | 0.62 | TSHR (0.41) | TSHR | |
| SCHEMBL9638829 | 0.62 | TSHR (0.46) | TSHR | |
| SCHEMBL9638454 | 0.62 | TSHR (0.41) | TSHR | |
| SCHEMBL2488748 | 0.62 | TSHR (0.41) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6696595-B2 | ESTERIFYING AN ADAMANTANE COMPOUND HAVING AN -OH GROUP, -OM GROUP OR OR DIVALENT ALIPHATIC HYDROCARBON GROUP, AND DISTILLING THE ESTER PRODUCT IN PRESENCE OF AN INERT HETEROCYCLIC COMPOUND WHICH IS STABLE UNDER DISTILLATION | TOKUYAMA CORPORATION (JP) | 2004-02-24 | — | — | US | claimed |
| US-20030120107-A1 | Process of the preparation of high-purity alkyladamantyl esters | TOKUYAMA CORPORATION (JP) | 2003-06-26 | — | — | US | claimed |
| EP-1284256-A1 | PROCESS OF THE PREPARATION OF HIGH-PURITY ALKYLADAMANTYL ESTERS | TOKUYAMA CORPORATION (JP) | 2003-02-19 | — | — | EP | claimed |
| JP-2008303218-A | METHOD FOR PRODUCING (METH)ACRYLATE | MITSUBISHI CHEMICALS CORP | 2008-12-18 | — | — | JP | disclosed |
| US-20080051597-A1 | Process for Producing 2-Methyladamantan-2-Yl (Meth)Acrylate and 2-Methyladamantan-2-Yl (Meth)Acrylate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-02-28 | — | — | US | disclosed |
| US-6861552-B2 | Adamantyl ester monomer composition | TOKUYAMA CORPORATION (JP) | 2005-03-01 | — | — | US | disclosed |
| US-6696595-B2 | ESTERIFYING AN ADAMANTANE COMPOUND HAVING AN -OH GROUP, -OM GROUP OR OR DIVALENT ALIPHATIC HYDROCARBON GROUP, AND DISTILLING THE ESTER PRODUCT IN PRESENCE OF AN INERT HETEROCYCLIC COMPOUND WHICH IS STABLE UNDER DISTILLATION | TOKUYAMA CORPORATION (JP) | 2004-02-24 | — | — | US | disclosed |
| US-20040015008-A1 | Adamantyl ester monomer composition | TOKUYAMA CORPORATION (JP) | 2004-01-22 | — | — | US | disclosed |
| US-20030120107-A1 | Process of the preparation of high-purity alkyladamantyl esters | TOKUYAMA CORPORATION (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1306363-A1 | ADAMANTYL ESTER MONOMER COMPOSITION | TOKUYAMA CORPORATION (JP) | 2003-05-02 | — | — | EP | disclosed |
| EP-1284256-A1 | PROCESS OF THE PREPARATION OF HIGH-PURITY ALKYLADAMANTYL ESTERS | TOKUYAMA CORPORATION (JP) | 2003-02-19 | — | — | EP | disclosed |
| JP-2002284739-A | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTER | MITSUBISHI CHEMICALS CORP | 2002-10-03 | — | — | JP | disclosed |
| JP-2002047216-A | METHOD FOR PRODUCING 2-ALKYLIDENEADAMANTANE | MITSUBISHI CHEMICALS CORP | 2002-02-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040015008-A1 | Adamantyl ester monomer composition | PRMT1, HSD11B1, HSD3B1 | TSHR 4693/4885 |
| US-20030120107-A1 | Process of the preparation of high-purity alkyladamantyl esters | TET2, MSMO1, ACMSD | TSHR 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.